News

On March 24, 2025, the Vatican opened its doors to a remarkable gathering of scientists, ethicists, and global thought leaders for the Vatican Longevity Summit. Held as part of the Jubilee of Hope and organized by the Pontifical Academy for Life, this event was a beacon of innovation, exploring the science and ethics of extending human life. In synergy with the Milan Longevity Summit, it brought together Nobel Prize laureates, biotechnology pioneers, and experts in artificial intelligence (AI) t …

Driving Scientific Innovation with ABM's Cutting-Edge Products Gentaur has long been the trusted distributor of Applied Biological Materials (ABM), providing researchers with high-quality reagents, cell lines, enzymes, and molecular biology tools across Belgium and Europe. Our commitment to fast delivery, competitive pricing, and expert support has made Gentaur the preferred choice for thousands of laboratories. ABM’s Product Categories Available at Gentaur As a leading distributor of ABM …

From SCSOmics 2024 to 2025: Single-Cell Passion Ignites Again ! We’re still buzzing from Single-Cell and Spatial Omics 2024 (SCSOmics 2024)—and with photos to prove it, we’re ready to relive the magic while gearing up for SCSOmics 2025! This powerhouse conference is back September 9–12, 2025, at KU Leuven Faculty of Social Sciences in Leuven, Belgium, uniting the brightest minds in single-cell and spatial omics. But first, let’s rewind to last year’s unforge …

Introduction to Qualitative and Quantitative Analysis in WB, IHC, IF, and FC Western Blot (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), and Flow Cytometry (FC) are widely used techniques in biological and clinical research. Proper qualitative and quantitative analysis of these results is essential for obtaining reliable conclusions. This guide provides best practices for analyzing WB, IHC, IF, and FC data with optimized methodologies and statistical tools. Western Blot (WB) Ana …

​Metastatic melanoma presents significant treatment challenges, but advancements in immunotherapy, particularly the combination of Sargramostim (rhu GM-CSF) and immune checkpoint inhibitors, offer promising therapeutic avenues. This article delves into the synergistic mechanisms, clinical efficacy, safety profiles, and future directions of this combinatorial approach. Introduction to Sargramostim and Immune Checkpoint Inhibitors in Metastatic Melanoma Immune checkpoint inhibitors (ICIs) have rev …